I would love to know where they are at with the application for the Rare Pediatric Disease Voucher. Can only see this being a catalyst for a SP appreciation in the foreseeable future.
The Chairmans address at the AGM mentioned the overall quality and meaningfulness of the clinical data generated in the Neuren Phase 2 studies will be further corroborated when the Phase 2 pediatric study is accepted for publication in a peer-reviewed journal. The manuscript has been submitted and they are just waiting for acceptance and possible publication dates.
- Forums
- ASX - By Stock
- NEU
- the BIG reversal
the BIG reversal, page-2
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$21.97 |
Change
0.975(4.65%) |
Mkt cap ! $2.805B |
Open | High | Low | Value | Volume |
$21.50 | $22.13 | $21.50 | $8.096M | 370.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 1605 | $21.96 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$21.97 | 38 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
17 | 1616 | 21.960 |
15 | 535 | 21.950 |
10 | 820 | 21.940 |
9 | 592 | 21.930 |
5 | 423 | 21.920 |
Price($) | Vol. | No. |
---|---|---|
21.970 | 75 | 5 |
21.980 | 220 | 8 |
21.990 | 340 | 4 |
22.000 | 7985 | 13 |
22.010 | 504 | 6 |
Last trade - 14.27pm 17/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |